Current Environment: Production

Eli Sprecher | Medical Services

Programs & Services

Languages

  • English

Eli Sprecher | Education

Undergraduate School

Harvard College

2005, Cambridge, MA

Graduate School

Harvard Kennedy School of Government

2011, Cambridge, MA

Medical School

Mount Sinai School of Medicine

2011, New York, NY

Internship

Boston Combined Residency Program (BCRP)

2011, Boston, MA

Residency

Boston Combined Residency Program (BCRP)

2014, Boston, MA

Fellowship

General Academic Pediatric

Boston Children's Hospital

2017, Boston, MA

Eli Sprecher | Certifications

  • American Board of Pediatrics (General)

Eli Sprecher | Professional History

In addition to clinical practice, I work in improving systems of care for children.

Eli Sprecher | Publications

  1. "I'm His Voice": Parent Perspectives on Obtaining an Autism Diagnosis and Services and the Influence of Personal and Cultural Factors. J Autism Dev Disord. 2024 Sep 26. View "I'm His Voice": Parent Perspectives on Obtaining an Autism Diagnosis and Services and the Influence of Personal and Cultural Factors. Abstract

  2. Improving Asthma Action Plan Completion Rates across Five Divisions in an Academic Children's Hospital. Pediatr Qual Saf. 2023 Nov-Dec; 8(6):e700. View Improving Asthma Action Plan Completion Rates across Five Divisions in an Academic Children's Hospital. Abstract

  3. Impact of the COVID-19 Pandemic on Childhood Lead Testing and Blood Lead Levels. Acad Pediatr. 2024 07; 24(5):810-814. View Impact of the COVID-19 Pandemic on Childhood Lead Testing and Blood Lead Levels. Abstract

  4. Categorization of a Universal Coding System to Distinguish Use of Durable Medical Equipment and Supplies in Pediatric Patients. JAMA Netw Open. 2023 10 02; 6(10):e2339449. View Categorization of a Universal Coding System to Distinguish Use of Durable Medical Equipment and Supplies in Pediatric Patients. Abstract

  5. A Mixed-Methods Assessment of Coronavirus Disease of 2019-Era Telehealth Acute Care Visits in the Medical Home. J Pediatr. 2023 04; 255:121-127.e2. View A Mixed-Methods Assessment of Coronavirus Disease of 2019-Era Telehealth Acute Care Visits in the Medical Home. Abstract

  6. Randomized Controlled Trial of Health Coaching for Parents of Children With Medical Complexity. Acad Pediatr. 2022 Nov-Dec; 22(8):1482-1488. View Randomized Controlled Trial of Health Coaching for Parents of Children With Medical Complexity. Abstract

  7. Machine learning approaches to predicting no-shows in pediatric medical appointment. NPJ Digit Med. 2022 Apr 20; 5(1):50. View Machine learning approaches to predicting no-shows in pediatric medical appointment. Abstract

  8. Association of a Third Dose of BNT162b2 Vaccine With Incidence of SARS-CoV-2 Infection Among Health Care Workers in Israel. JAMA. 2022 01 25; 327(4):341-349. View Association of a Third Dose of BNT162b2 Vaccine With Incidence of SARS-CoV-2 Infection Among Health Care Workers in Israel. Abstract

  9. Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers. JAMA. 2021 Jun 22; 325(24):2457-2465. View Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers. Abstract

  10. Laboratory monitoring during antifungal treatment of paediatric tinea capitis. Mycoses. 2021 Feb; 64(2):157-161. View Laboratory monitoring during antifungal treatment of paediatric tinea capitis. Abstract

  11. The Role of COVID-19 in Transitioning to a Better Pediatric Payment Model. Pediatrics. 2021 01; 147(1). View The Role of COVID-19 in Transitioning to a Better Pediatric Payment Model. Abstract

  12. The Role of Desmoglein 1 in Gap Junction Turnover Revealed through the Study of SAM Syndrome. J Invest Dermatol. 2020 03; 140(3):556-567.e9. View The Role of Desmoglein 1 in Gap Junction Turnover Revealed through the Study of SAM Syndrome. Abstract

  13. Griseofulvin vs terbinafine for paediatric tinea capitis: When and for how long. Mycoses. 2019 Oct; 62(10):949-953. View Griseofulvin vs terbinafine for paediatric tinea capitis: When and for how long. Abstract

  14. Telemedicine and Antibiotic Use: One Click Forward or Two Steps Back? Pediatrics. 2019 09; 144(3). View Telemedicine and Antibiotic Use: One Click Forward or Two Steps Back? Abstract

  15. Use of Social Psychology to Improve Adherence to National Bronchiolitis Guidelines. Pediatrics. 2019 01; 143(1). View Use of Social Psychology to Improve Adherence to National Bronchiolitis Guidelines. Abstract

  16. Ensuring Timely Connection to Early Intervention for Young Children With Developmental Delays. Pediatrics. 2018 07; 142(1). View Ensuring Timely Connection to Early Intervention for Young Children With Developmental Delays. Abstract

  17. Fractional ablative carbon dioxide laser followed by topical sodium stibogluconate application: A treatment option for pediatric cutaneous leishmaniasis. Pediatr Dermatol. 2018 May; 35(3):366-369. View Fractional ablative carbon dioxide laser followed by topical sodium stibogluconate application: A treatment option for pediatric cutaneous leishmaniasis. Abstract

  18. Utilization of Patient Navigators in an Urban Academic Pediatric Primary Care Practice. Clin Pediatr (Phila). 2018 09; 57(10):1154-1160. View Utilization of Patient Navigators in an Urban Academic Pediatric Primary Care Practice. Abstract

  19. Assessment of the effectiveness of topical propranolol 4% gel for infantile hemangiomas. Int J Dermatol. 2017 Feb; 56(2):148-153. View Assessment of the effectiveness of topical propranolol 4% gel for infantile hemangiomas. Abstract

  20. Tinea capitis outbreak among paediatric refugee population, an evolving healthcare challenge. Mycoses. 2016 Sep; 59(9):553-7. View Tinea capitis outbreak among paediatric refugee population, an evolving healthcare challenge. Abstract

  21. How Accountable Care Organizations Responded to Pediatric Incentives in the Alternative Quality Contract. Acad Pediatr. 2016 Mar; 16(2):200-7. View How Accountable Care Organizations Responded to Pediatric Incentives in the Alternative Quality Contract. Abstract

  22. Autosomal dominant inheritance of central centrifugal cicatricial alopecia in black South Africans. J Am Acad Dermatol. 2014 Apr; 70(4):679-682.e1. View Autosomal dominant inheritance of central centrifugal cicatricial alopecia in black South Africans. Abstract

  23. Influence of glutathione S-transferase A1, P1, M1, T1 polymorphisms on oral busulfan pharmacokinetics in children with congenital hemoglobinopathies undergoing hematopoietic stem cell transplantation. Pediatr Blood Cancer. 2010 Dec 01; 55(6):1172-9. View Influence of glutathione S-transferase A1, P1, M1, T1 polymorphisms on oral busulfan pharmacokinetics in children with congenital hemoglobinopathies undergoing hematopoietic stem cell transplantation. Abstract

  24. A systematic review of US state environmental legislation and regulation with regards to the prevention of neurodevelopmental disabilities and asthma. Environ Health. 2009 Mar 26; 8:9. View A systematic review of US state environmental legislation and regulation with regards to the prevention of neurodevelopmental disabilities and asthma. Abstract

  25. ABCA12 is the major harlequin ichthyosis gene. J Invest Dermatol. 2006 Nov; 126(11):2408-13. View ABCA12 is the major harlequin ichthyosis gene. Abstract

  26. Partial treatment interruption of protease inhibitor-based highly active antiretroviral therapy regimens in HIV-infected children. J Acquir Immune Defic Syndr. 2006 Mar; 41(3):298-303. View Partial treatment interruption of protease inhibitor-based highly active antiretroviral therapy regimens in HIV-infected children. Abstract

  27. The alopecias associated with vitamin D-dependent rickets type IIA and with hairless gene mutations: a comparative clinical, histologic, and immunohistochemical study. Arch Dermatol. 2005 Mar; 141(3):343-51. View The alopecias associated with vitamin D-dependent rickets type IIA and with hairless gene mutations: a comparative clinical, histologic, and immunohistochemical study. Abstract

I strive to provide high-quality, evidence-based, equitable, whole-child care to all.

BESbswy